{"name":"TASK Applied Science","slug":"task-applied-science","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Infectious Disease","slug":"infectious-disease","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"Amoxycillin/clavulanic acid","genericName":"Amoxycillin/clavulanic acid","slug":"amoxycillin-clavulanic-acid","indication":"Bacterial infections caused by susceptible organisms including otitis media, sinusitis, respiratory tract infections, urinary tract infections, skin and soft tissue infections, and intra-abdominal infections","status":"marketed"}]},{"name":"Oncology","slug":"oncology","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"immunology","drugs":[{"name":"Bacille Calmette-Guérin (BCG)","genericName":"Bacille Calmette-Guérin (BCG)","slug":"bacille-calmette-gu-rin-bcg","indication":"Non-muscle invasive bladder cancer (NMIBC), high-grade or recurrent","status":"marketed"}]}],"pipeline":[{"name":"Amoxycillin/clavulanic acid","genericName":"Amoxycillin/clavulanic acid","slug":"amoxycillin-clavulanic-acid","phase":"marketed","mechanism":"Amoxicillin inhibits bacterial cell wall synthesis by binding to penicillin-binding proteins, while clavulanic acid protects amoxicillin from degradation by beta-lactamase enzymes.","indications":["Bacterial infections caused by susceptible organisms including otitis media, sinusitis, respiratory tract infections, urinary tract infections, skin and soft tissue infections, and intra-abdominal infections"],"catalyst":""},{"name":"Bacille Calmette-Guérin (BCG)","genericName":"Bacille Calmette-Guérin (BCG)","slug":"bacille-calmette-gu-rin-bcg","phase":"marketed","mechanism":"BCG is a live attenuated mycobacterial vaccine that stimulates innate and adaptive immune responses to enhance anti-tumor immunity and treat bladder cancer.","indications":["Non-muscle invasive bladder cancer (NMIBC), high-grade or recurrent","Bladder cancer prophylaxis after transurethral resection"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMitgFBVV95cUxNWHVpN3laUWhRV20zMVhFaTFrOUdhRUM0TW9KcWRST3Bqd3FCYU5lUUl3ZUI5Q1FhNFotcXdTQkJ6QmN2dzV3SmE3R3k1MFhtbXRlX0NnYWw2MzkwX2RfakgxWVFRelNHU0F2QjgtSXJlMXpHbHE3RXpaT3VsWXFVUExuUDc1UDNmLUJYWF9hUVRMMGtXWm1nQU9rc0ZKQXl4ckpwRTg5TmJTcXdpRUhRSTk1bXl4dw?oc=5","date":"2026-02-06","type":"pipeline","source":"fiercehealthcare.com","summary":"Centene 'laser-focused' on improvements to Medicaid business, CEO London says - fiercehealthcare.com","headline":"Centene 'laser-focused' on improvements to Medicaid business, CEO London says","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiZkFVX3lxTE56M0lEWFluUlhtNGd5NTVRS0NkaHByVUdVRDRKWHotRWY1MTdsd2k2bjFneE5UWTUxbE5LSVpETmVEejB0ZVlTUDF3SGg3SUxnQXU2UlpXNkd1eTM1VmJpdllkZUIzQQ?oc=5","date":"2026-01-11","type":"pipeline","source":"Anthropic","summary":"Advancing Claude in healthcare and the life sciences - Anthropic","headline":"Advancing Claude in healthcare and the life sciences","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMingFBVV95cUxQOFpFNmY3Mm8walRlek8xSHZhZnpFU2ZsYjNtT2V0bnRZUm52S1I1NWVHbS11NnZsbDc3QzFQNXdWa1lqb241NDBpTUtueElhZkZNYUFxVkt2WVVVbGNtMU9kZ0JCQXp3UWVnTjNHUUNpZ3JjOGFtUUtUUzZNVm1tU3owSnpQbFBWSzdoSHlMenI2aEI5bDhpVE9UNTUyUQ?oc=5","date":"2025-12-08","type":"pipeline","source":"Pharmaceutical Commerce","summary":"How AI-Powered Precision Is Reshaping Medical Affairs - Pharmaceutical Commerce","headline":"How AI-Powered Precision Is Reshaping Medical Affairs","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi2gFBVV95cUxQN0hmQTJjaVQ4SzVrODBFUU5MakJwYWo1eVNsVFJjbmktM0VPSXFGcUE2MWtXN1VyNlVTVWR1Y0k1TVRyMG1ocXF6RWFmYkdfcVpaWC1CUVJ4SkpVRFlTX2JQUkZQclZ3czlVQ1lkaUVHc00waGdVcW9XQnpaRWlJcW1sTU41eG5EU2pPUzNTWUVLbGZmV0d5SHdXSjN5c2xGU0hDYnNlTzc0TmhVaEx4VnhGWm5Tc2dtel9PWC1oanM0Y0QzRW9nR2I1d3FFNy1fakV2RmtGTnhvZw?oc=5","date":"2025-11-18","type":"pipeline","source":"News-Medical","summary":"Scientists urge careful evaluation before applying AI virtual staining in healthcare workflows - News-Medical","headline":"Scientists urge careful evaluation before applying AI virtual staining in healthcare workflows - News","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiowFBVV95cUxNWHp2b3hKLXlwZ3Zua2p5Y0dXRDFlQVlZR0d5S1RScEZzUHhVdzFVSkQ1d2pmajMtX2ZoWWxlV2RGQjJOZ095ZWtPeXhTSHZScGVjSEtOcVdOLTdrN0EyRzUtZ1dSMlVjLXpibGkwX0IyTnFWMnNfOGlFcjNhMjVNNG8xMkpvcXBNV1U4OVM0VjdRclVLV2RoMTFmWjJ1MU1TNG5Z?oc=5","date":"2025-10-29","type":"pipeline","source":"SBU News","summary":"Stony Brook Leaders Named to SUNY Climate Research Task Force - SBU News","headline":"Stony Brook Leaders Named to SUNY Climate Research Task Force","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiZkFVX3lxTFB6ZkJDUjcyZGJOY1E2QlJxZWRqZ0w3ZThjc3pyMk02V0tMQ29ZMVVxV3F3WFhQMU9EZG1NN0x5bG5udE5ScWJCbkdndDYzSXR6aGRzcXR1TC1vT0x0OWw3UFdleThrUQ?oc=5","date":"2025-10-20","type":"pipeline","source":"Anthropic","summary":"Claude for Life Sciences - Anthropic","headline":"Claude for Life Sciences","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiX0FVX3lxTE04amdDaHlpcnIxeV9vUG1kQlRPX3ptcFA4T3NEdVJUWTF2STQ4d3dCRkVHU0VZQ1VrVGdmNG5tS3dPeEE2dUFWSHVWLWJrdnFfb05MY1Nsa2VnekxYUGlj?oc=5","date":"2025-09-26","type":"trial","source":"Nature","summary":"TrialBench: Multi-Modal AI-Ready Datasets for Clinical Trial Prediction - Scientific Data - Nature","headline":"TrialBench: Multi-Modal AI-Ready Datasets for Clinical Trial Prediction - Scientific Data","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiX0FVX3lxTE5pUFVNUklwaUZOSnMwSklvb1pkenBTaGQ2Z3hxZzZJMU80M2g2cF9aRzdtSDMxY0ZPdDI3b0k2Y3FYbVVFZ2VpWlVXRWVUZWZBakJKcVQybVFwSXl2djEw?oc=5","date":"2025-06-18","type":"pipeline","source":"Nature","summary":"Applying a multi-task and multi-instance framework to predict axillary lymph node metastases in breast cancer - Nature","headline":"Applying a multi-task and multi-instance framework to predict axillary lymph node metastases in breast cancer","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiXEFVX3lxTFBLcUwtTjZhRjZiTTI4R3VaTDhKZnJnenp4QlFMTHpMUGtmZkczbVFMNWFCd3VKekNZWDZNODJjaVhnZThFQ1czWUtVd255YW1KTXFYU25jWFlsbURZ?oc=5","date":"2025-03-05","type":"pipeline","source":"EurekAlert!","summary":"Insilico Medicine deploys the first bipedal humanoid AI scientist in the fully-robotic drug discovery laboratory - EurekAlert!","headline":"Insilico Medicine deploys the first bipedal humanoid AI scientist in the fully-robotic drug discovery laboratory - Eurek","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi0AFBVV95cUxQVXl3dWluaV9keW5sR19XVVlnUjl6VktfdXhIN21rZjE4elNDbldDMERQNmQtRUNJRWtfbHBWMm1sUzVmQkdlWUJKR2ZxR0twTDIwaXpoRGRGU25aT3dzQjRoMkQwVUhCZGw3QVZTR0JuNVlPUFJsYUk3OE9aOXFTa2NxZzl0cGlZNTM3ell5Zi0xRnNuN3lLcEh6MmFYNnZJYlNXMDlya3c0RFY3dWo0MU1OMHphdndZb2tsRk84Nzgtalp0cm40ZnNxcUtqVW1m?oc=5","date":"2024-01-09","type":"pipeline","source":"McKinsey & Company","summary":"Generative AI in the pharmaceutical industry: Moving from hype to reality - McKinsey & Company","headline":"Generative AI in the pharmaceutical industry: Moving from hype to reality - McKinsey & Company","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi8AFBVV95cUxNM0NlbHY5elRDeWptZ2tQel90ZS1sNkFORDl5eEFoM282Xy1uT3NuT1NPNHptLXlVVHlpQWx6eXVSZFJYUktvZk9uZUU3UTJHM01KVkZSd1JId2VIbzNKOXY1bXh1Y0xadzV5aFNxMWh3cGtvT1g2eXpxNnJqdTlrRTVwaDVRcVhmbnMxN3drS1dDaHpXU1Y5R0xmTlF4dmh5d1Jzc1hvbHpmS3FTVGpjMUQwNVdXcjFpRDIxajlybXZ5Q2gxejN6N1U3Y09Od1BOemVLc1NWc0JuZ01IbHl6ckJSbnV5OXlfRnhqVmtiMjY?oc=5","date":"2023-11-06","type":"trial","source":"appliedclinicaltrialsonline.com","summary":"Creating Strategic Relationships: The Changing Face of Contract Research Organizations and Sponsor Partnerships - appliedclinicaltrialsonline.com","headline":"Creating Strategic Relationships: The Changing Face of Contract Research Organizations and Sponsor Partnerships","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiigFBVV95cUxQWjVxeTFDQXFtVXdnOXJCdTFZd3dPLXdUcjF1T2ZwcGJUU3lhd2VrSGg2a2VkWW5LQ21nUnI3QkJwRWlTbTFJbnhMSDZFRVc5NDljckdibDl0NS1ncVlqQ0FSUV9ZN1M0SHZpQmJvdDE2MGtYNmJEZWxCcDZkQXVuSG1sZUlSRWFfUHc?oc=5","date":"2022-11-03","type":"pipeline","source":"Center for a New American Security | CNAS","summary":"CNAS Task Force on Biotechnology and American Competitiveness - Center for a New American Security | CNAS","headline":"CNAS Task Force on Biotechnology and American Competitiveness - Center for a New American Security | CNAS","sentiment":"neutral"}],"patents":[],"drugCount":2,"phaseCounts":{"marketed":2},"enrichmentLevel":0,"visitCount":3,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}